PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies

By Winer Eric S   Ingham Randall R   Castillo Jorge J  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 3, 2012-03 ,pp. : 355-361

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of phosphatidylinositol 3-kinase

By Zahradka P.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 97-99

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Phosphatidylinositol 3-Kinase/AKT Pathway for the Treatment of Multiple Myeloma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 27, 2014-09 ,pp. : 3173-3187

Bentham Science Publishers

Access to resources Recommend Favorite

The phosphatidylinositol 3-kinase inhibitor wortmannin markedly reduces chemotactic peptide-induced locomotion and increases in cytoskeletal actin in human neutrophils

By Niggli V.   Keller H.  

European Journal of Pharmacology, Vol. 335, Iss. 1, 1997-09 ,pp. : 43-52

Elsevier

Access to resources Recommend Favorite

Effect of phosphatidylinositol 3-kinase-γ inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats

By Tyagi Sandeep   Sharma Saurabh   Budhiraja Ramji Dass  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 7, 2012-07 ,pp. : 881-885

NRC Research Press

Access to resources Recommend Favorite